Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Obstetrics & Gynecology
- The clinical spectrum of autoimmune congenital heart block.Nat Rev Rheumatol. 2015; 11: 301-312
- Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women.Arthritis Rheum. 2001; 44: 1832-1835
- Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies.J Pediatr. 2003; 142: 678-683
- Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors.Arthritis Rheum. 2009; 60: 3091-3097
- Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association.Circulation. 2014; 129: 2183-2242
- Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study.Circulation. 2008; 117: 485-493
- Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA/Ro-positive mothers.J Am Coll Cardiol. 2020; 76: 292-302
- Home monitoring for fetal heart rhythm during anti-Ro pregnancies.J Am Coll Cardiol. 2018; 72: 1940-1951
- Detection and successful treatment of emergent anti-SSA-mediated fetal atrioventricular block.Am J Obstet Gynecol. 2016; 215: 527-528
- Umbilical cord blood levels of maternal antibodies reactive with p200 and full-length Ro 52 in the assessment of risk for cardiac manifestations of neonatal lupus.Arthritis Care Res (Hoboken). 2012; 64: 1373-1381
- The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.J Am Coll Cardiol. 2010; 55: 2778-2784
- Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus.J Clin Invest. 1989; 84: 627-634
- Echocardiographic studies of the human fetus: prenatal diagnosis of congenital heart disease and cardiac dysrhythmias.Pediatrics. 1980; 65: 1059-1067
- Doppler echocardiography in the diagnosis and management of persistent fetal arrhythmias.J Am Coll Cardiol. 1986; 7: 1386-1391
- Performance of a multiplex assay compared to enzyme and precipitation methods for anti-ENA testing in systemic lupus and systemic sclerosis.J Immunol Methods. 2011; 365: 126-131
- quantreg: quantile regression.(Available at:)https://cran.r-project.org/web/packages/quantreg/index.htmlDate: 2021Date accessed: March 1, 2022
- Birth order, gender and recurrence rate in autoantibody-associated congenital heart block: implications for pathogenesis and family counseling.Lupus. 2003; 12: 646-647
- Routine repeated echocardiographic monitoring of fetuses exposed to maternal anti-SSA antibodies: time to question the dogma.Lancet Rheumatol. 2019; 1: e187-e193
- Prenatal heart block screening in mothers with SSA/SSB autoantibodies: targeted screening protocol is a cost-effective strategy.Congenit Heart Dis. 2019; 14: 221-229
- Targeting downstream transcription factors and epigenetic modifications following toll-like receptor 7/8 ligation to forestall tissue injury in anti-Ro60 associated heart block.J Autoimmun. 2016; 67: 36-45
Publication stageIn Press Journal Pre-Proof
J.P.B. and B.F.C. contributed equally to this work as senior authors.
The authors report no conflict of interest.
This work was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development , United States (grant number R01 HD100929 [J.P.B. and B.F.C]), National Institute of Arthritis and Musculoskeletal and Skin Diseases , United States (grant numbers R37 AR042455 and N01 AR42271 [J.P.B.]), and National Heart, Lung, and Blood Institute , United States (K01 grant number HL151754 [A.M.K.]). The Associated Regional and University Pathologists Laboratories provided a grant to perform the anti-Ro/SSA antibody assays from New York University subjects. The funding sources were not involved in the study design, data collection, data analysis and interpretation, manuscript preparation, or manuscript submission.
Cite this article as: Kaizer AM, Lindblade C, Clancy R, et al. Reducing the burden of surveillance in pregnant women with no history of fetal atrioventricular block using the negative predictive value of anti-Ro/SSA antibody titers. Am J Obstet Gynecol 2022;XX:x.ex–x.ex.